Analysis shows higher mortality risk in anti-MDA5 dermatomyositis patients, suggesting a nomogram for risk stratification.
Anti-MDA5 antibody positivity was strongly associated with higher short-term mortality in DM-ILD. The proposed nomogram, integrating RP-ILD, ALB, CRP, ferritin, and NLR, showed robust predictive accuracy and may aid individualized risk stratification. External validation is warranted.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: